JAMA SURG 润色咨询

JAMA Surgery

出版年份:暂无数据 年文章数:949 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2155599, encodeId=fd8521555996b, content=记录一下这次不知死活的试探(成功概率P&lt;0.05)<br>under review 16天<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 12:14:46 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2146688, encodeId=4c90214668893, content=投稿命中率:5.0<br>偏重的研究方向:外科<br>经验分享:Under review 17 天,请问多久知道是送审了没有呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu Jul 06 21:45:48 CST 2023, time=2023-07-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2137790, encodeId=f6eb213e79000, content=偏重的研究方向:外科<br>经验分享:期刊收录的都是临床研究,希望中的人多分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KiaoPdfCzZ3xibjx7qwz8Ll35hLHUNHUqFubpg8qXJV9IKFic7I9fxFYGbDJTicpcu8ib5GUEuUFwMSfdAYnThsjZ1Q/132, createdBy=1b4f2360060, createdName=爱您一万年, createdTime=Fri May 19 06:07:49 CST 2023, time=2023-05-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1087443, encodeId=ad03108e44387, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016043, encodeId=f50d10160431a, content=偏重的研究方向:肿瘤外科<br>经验分享:10天 under review,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/16aca09327e6e9fe8409019894c494a0.jpg, createdBy=e7772226610, createdName=121148d5m08暂无昵称, createdTime=Thu Sep 09 13:18:28 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544290, encodeId=488d5442903c, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095062, encodeId=3376209506277, content=好中吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3c31972528, createdName=Frontiers主编, createdTime=Thu Oct 20 22:44:01 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087444, encodeId=958d108e44485, content=期刊发送邮件中包括哪几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085116, encodeId=cd051085116d7, content=圣诞节对审稿影响多少,21号投的稿现在没有消息,有没有送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da85597851, createdName=ms8000000068856168, createdTime=Tue Dec 28 15:56:39 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923874, encodeId=d8ad9238e487, content=已under review 5天,还没被拒,说明已送审?<br>应该还不保险,10天左右没被拒,大概是送审了。<br>上一次投稿,4天被拒。期待,不行赶快有结果,好去转投BJS。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Feb 09 11:39:23 CST 2021, time=2021-02-09, status=1, ipAttribution=)]
    2023-09-01 ms3000001344629820 来自陕西省

    记录一下这次不知死活的试探(成功概率P<0.05)
    under review 16天

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2155599, encodeId=fd8521555996b, content=记录一下这次不知死活的试探(成功概率P&lt;0.05)<br>under review 16天<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 12:14:46 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2146688, encodeId=4c90214668893, content=投稿命中率:5.0<br>偏重的研究方向:外科<br>经验分享:Under review 17 天,请问多久知道是送审了没有呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu Jul 06 21:45:48 CST 2023, time=2023-07-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2137790, encodeId=f6eb213e79000, content=偏重的研究方向:外科<br>经验分享:期刊收录的都是临床研究,希望中的人多分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KiaoPdfCzZ3xibjx7qwz8Ll35hLHUNHUqFubpg8qXJV9IKFic7I9fxFYGbDJTicpcu8ib5GUEuUFwMSfdAYnThsjZ1Q/132, createdBy=1b4f2360060, createdName=爱您一万年, createdTime=Fri May 19 06:07:49 CST 2023, time=2023-05-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1087443, encodeId=ad03108e44387, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016043, encodeId=f50d10160431a, content=偏重的研究方向:肿瘤外科<br>经验分享:10天 under review,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/16aca09327e6e9fe8409019894c494a0.jpg, createdBy=e7772226610, createdName=121148d5m08暂无昵称, createdTime=Thu Sep 09 13:18:28 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544290, encodeId=488d5442903c, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095062, encodeId=3376209506277, content=好中吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3c31972528, createdName=Frontiers主编, createdTime=Thu Oct 20 22:44:01 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087444, encodeId=958d108e44485, content=期刊发送邮件中包括哪几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085116, encodeId=cd051085116d7, content=圣诞节对审稿影响多少,21号投的稿现在没有消息,有没有送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da85597851, createdName=ms8000000068856168, createdTime=Tue Dec 28 15:56:39 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923874, encodeId=d8ad9238e487, content=已under review 5天,还没被拒,说明已送审?<br>应该还不保险,10天左右没被拒,大概是送审了。<br>上一次投稿,4天被拒。期待,不行赶快有结果,好去转投BJS。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Feb 09 11:39:23 CST 2021, time=2021-02-09, status=1, ipAttribution=)]
    2023-07-06 ms3000001735198901 来自四川省

    投稿命中率:5.0
    偏重的研究方向:外科
    经验分享:Under review 17 天,请问多久知道是送审了没有呢?

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2155599, encodeId=fd8521555996b, content=记录一下这次不知死活的试探(成功概率P&lt;0.05)<br>under review 16天<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 12:14:46 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2146688, encodeId=4c90214668893, content=投稿命中率:5.0<br>偏重的研究方向:外科<br>经验分享:Under review 17 天,请问多久知道是送审了没有呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu Jul 06 21:45:48 CST 2023, time=2023-07-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2137790, encodeId=f6eb213e79000, content=偏重的研究方向:外科<br>经验分享:期刊收录的都是临床研究,希望中的人多分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KiaoPdfCzZ3xibjx7qwz8Ll35hLHUNHUqFubpg8qXJV9IKFic7I9fxFYGbDJTicpcu8ib5GUEuUFwMSfdAYnThsjZ1Q/132, createdBy=1b4f2360060, createdName=爱您一万年, createdTime=Fri May 19 06:07:49 CST 2023, time=2023-05-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1087443, encodeId=ad03108e44387, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016043, encodeId=f50d10160431a, content=偏重的研究方向:肿瘤外科<br>经验分享:10天 under review,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/16aca09327e6e9fe8409019894c494a0.jpg, createdBy=e7772226610, createdName=121148d5m08暂无昵称, createdTime=Thu Sep 09 13:18:28 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544290, encodeId=488d5442903c, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095062, encodeId=3376209506277, content=好中吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3c31972528, createdName=Frontiers主编, createdTime=Thu Oct 20 22:44:01 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087444, encodeId=958d108e44485, content=期刊发送邮件中包括哪几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085116, encodeId=cd051085116d7, content=圣诞节对审稿影响多少,21号投的稿现在没有消息,有没有送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da85597851, createdName=ms8000000068856168, createdTime=Tue Dec 28 15:56:39 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923874, encodeId=d8ad9238e487, content=已under review 5天,还没被拒,说明已送审?<br>应该还不保险,10天左右没被拒,大概是送审了。<br>上一次投稿,4天被拒。期待,不行赶快有结果,好去转投BJS。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Feb 09 11:39:23 CST 2021, time=2021-02-09, status=1, ipAttribution=)]
    2023-05-19 爱您一万年 来自浙江省

    偏重的研究方向:外科
    经验分享:期刊收录的都是临床研究,希望中的人多分享经验

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2155599, encodeId=fd8521555996b, content=记录一下这次不知死活的试探(成功概率P&lt;0.05)<br>under review 16天<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 12:14:46 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2146688, encodeId=4c90214668893, content=投稿命中率:5.0<br>偏重的研究方向:外科<br>经验分享:Under review 17 天,请问多久知道是送审了没有呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu Jul 06 21:45:48 CST 2023, time=2023-07-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2137790, encodeId=f6eb213e79000, content=偏重的研究方向:外科<br>经验分享:期刊收录的都是临床研究,希望中的人多分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KiaoPdfCzZ3xibjx7qwz8Ll35hLHUNHUqFubpg8qXJV9IKFic7I9fxFYGbDJTicpcu8ib5GUEuUFwMSfdAYnThsjZ1Q/132, createdBy=1b4f2360060, createdName=爱您一万年, createdTime=Fri May 19 06:07:49 CST 2023, time=2023-05-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1087443, encodeId=ad03108e44387, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016043, encodeId=f50d10160431a, content=偏重的研究方向:肿瘤外科<br>经验分享:10天 under review,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/16aca09327e6e9fe8409019894c494a0.jpg, createdBy=e7772226610, createdName=121148d5m08暂无昵称, createdTime=Thu Sep 09 13:18:28 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544290, encodeId=488d5442903c, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095062, encodeId=3376209506277, content=好中吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3c31972528, createdName=Frontiers主编, createdTime=Thu Oct 20 22:44:01 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087444, encodeId=958d108e44485, content=期刊发送邮件中包括哪几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085116, encodeId=cd051085116d7, content=圣诞节对审稿影响多少,21号投的稿现在没有消息,有没有送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da85597851, createdName=ms8000000068856168, createdTime=Tue Dec 28 15:56:39 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923874, encodeId=d8ad9238e487, content=已under review 5天,还没被拒,说明已送审?<br>应该还不保险,10天左右没被拒,大概是送审了。<br>上一次投稿,4天被拒。期待,不行赶快有结果,好去转投BJS。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Feb 09 11:39:23 CST 2021, time=2021-02-09, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    期刊给我发了一封信,但我看不懂怎么办?

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2155599, encodeId=fd8521555996b, content=记录一下这次不知死活的试探(成功概率P&lt;0.05)<br>under review 16天<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 12:14:46 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2146688, encodeId=4c90214668893, content=投稿命中率:5.0<br>偏重的研究方向:外科<br>经验分享:Under review 17 天,请问多久知道是送审了没有呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu Jul 06 21:45:48 CST 2023, time=2023-07-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2137790, encodeId=f6eb213e79000, content=偏重的研究方向:外科<br>经验分享:期刊收录的都是临床研究,希望中的人多分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KiaoPdfCzZ3xibjx7qwz8Ll35hLHUNHUqFubpg8qXJV9IKFic7I9fxFYGbDJTicpcu8ib5GUEuUFwMSfdAYnThsjZ1Q/132, createdBy=1b4f2360060, createdName=爱您一万年, createdTime=Fri May 19 06:07:49 CST 2023, time=2023-05-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1087443, encodeId=ad03108e44387, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016043, encodeId=f50d10160431a, content=偏重的研究方向:肿瘤外科<br>经验分享:10天 under review,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/16aca09327e6e9fe8409019894c494a0.jpg, createdBy=e7772226610, createdName=121148d5m08暂无昵称, createdTime=Thu Sep 09 13:18:28 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544290, encodeId=488d5442903c, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095062, encodeId=3376209506277, content=好中吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3c31972528, createdName=Frontiers主编, createdTime=Thu Oct 20 22:44:01 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087444, encodeId=958d108e44485, content=期刊发送邮件中包括哪几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085116, encodeId=cd051085116d7, content=圣诞节对审稿影响多少,21号投的稿现在没有消息,有没有送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da85597851, createdName=ms8000000068856168, createdTime=Tue Dec 28 15:56:39 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923874, encodeId=d8ad9238e487, content=已under review 5天,还没被拒,说明已送审?<br>应该还不保险,10天左右没被拒,大概是送审了。<br>上一次投稿,4天被拒。期待,不行赶快有结果,好去转投BJS。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Feb 09 11:39:23 CST 2021, time=2021-02-09, status=1, ipAttribution=)]
    2021-09-09 121148d5m08暂无昵称

    偏重的研究方向:肿瘤外科
    经验分享:10天 under review,送外审了吗?

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2155599, encodeId=fd8521555996b, content=记录一下这次不知死活的试探(成功概率P&lt;0.05)<br>under review 16天<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 12:14:46 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2146688, encodeId=4c90214668893, content=投稿命中率:5.0<br>偏重的研究方向:外科<br>经验分享:Under review 17 天,请问多久知道是送审了没有呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu Jul 06 21:45:48 CST 2023, time=2023-07-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2137790, encodeId=f6eb213e79000, content=偏重的研究方向:外科<br>经验分享:期刊收录的都是临床研究,希望中的人多分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KiaoPdfCzZ3xibjx7qwz8Ll35hLHUNHUqFubpg8qXJV9IKFic7I9fxFYGbDJTicpcu8ib5GUEuUFwMSfdAYnThsjZ1Q/132, createdBy=1b4f2360060, createdName=爱您一万年, createdTime=Fri May 19 06:07:49 CST 2023, time=2023-05-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1087443, encodeId=ad03108e44387, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016043, encodeId=f50d10160431a, content=偏重的研究方向:肿瘤外科<br>经验分享:10天 under review,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/16aca09327e6e9fe8409019894c494a0.jpg, createdBy=e7772226610, createdName=121148d5m08暂无昵称, createdTime=Thu Sep 09 13:18:28 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544290, encodeId=488d5442903c, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095062, encodeId=3376209506277, content=好中吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3c31972528, createdName=Frontiers主编, createdTime=Thu Oct 20 22:44:01 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087444, encodeId=958d108e44485, content=期刊发送邮件中包括哪几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085116, encodeId=cd051085116d7, content=圣诞节对审稿影响多少,21号投的稿现在没有消息,有没有送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da85597851, createdName=ms8000000068856168, createdTime=Tue Dec 28 15:56:39 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923874, encodeId=d8ad9238e487, content=已under review 5天,还没被拒,说明已送审?<br>应该还不保险,10天左右没被拒,大概是送审了。<br>上一次投稿,4天被拒。期待,不行赶快有结果,好去转投BJS。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Feb 09 11:39:23 CST 2021, time=2021-02-09, status=1, ipAttribution=)]
    2017-07-16 13805560183

    赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2155599, encodeId=fd8521555996b, content=记录一下这次不知死活的试探(成功概率P&lt;0.05)<br>under review 16天<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 12:14:46 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2146688, encodeId=4c90214668893, content=投稿命中率:5.0<br>偏重的研究方向:外科<br>经验分享:Under review 17 天,请问多久知道是送审了没有呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu Jul 06 21:45:48 CST 2023, time=2023-07-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2137790, encodeId=f6eb213e79000, content=偏重的研究方向:外科<br>经验分享:期刊收录的都是临床研究,希望中的人多分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KiaoPdfCzZ3xibjx7qwz8Ll35hLHUNHUqFubpg8qXJV9IKFic7I9fxFYGbDJTicpcu8ib5GUEuUFwMSfdAYnThsjZ1Q/132, createdBy=1b4f2360060, createdName=爱您一万年, createdTime=Fri May 19 06:07:49 CST 2023, time=2023-05-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1087443, encodeId=ad03108e44387, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016043, encodeId=f50d10160431a, content=偏重的研究方向:肿瘤外科<br>经验分享:10天 under review,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/16aca09327e6e9fe8409019894c494a0.jpg, createdBy=e7772226610, createdName=121148d5m08暂无昵称, createdTime=Thu Sep 09 13:18:28 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544290, encodeId=488d5442903c, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095062, encodeId=3376209506277, content=好中吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3c31972528, createdName=Frontiers主编, createdTime=Thu Oct 20 22:44:01 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087444, encodeId=958d108e44485, content=期刊发送邮件中包括哪几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085116, encodeId=cd051085116d7, content=圣诞节对审稿影响多少,21号投的稿现在没有消息,有没有送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da85597851, createdName=ms8000000068856168, createdTime=Tue Dec 28 15:56:39 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923874, encodeId=d8ad9238e487, content=已under review 5天,还没被拒,说明已送审?<br>应该还不保险,10天左右没被拒,大概是送审了。<br>上一次投稿,4天被拒。期待,不行赶快有结果,好去转投BJS。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Feb 09 11:39:23 CST 2021, time=2021-02-09, status=1, ipAttribution=)]
    2022-10-20 Frontiers主编

    好中吗?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2155599, encodeId=fd8521555996b, content=记录一下这次不知死活的试探(成功概率P&lt;0.05)<br>under review 16天<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 12:14:46 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2146688, encodeId=4c90214668893, content=投稿命中率:5.0<br>偏重的研究方向:外科<br>经验分享:Under review 17 天,请问多久知道是送审了没有呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu Jul 06 21:45:48 CST 2023, time=2023-07-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2137790, encodeId=f6eb213e79000, content=偏重的研究方向:外科<br>经验分享:期刊收录的都是临床研究,希望中的人多分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KiaoPdfCzZ3xibjx7qwz8Ll35hLHUNHUqFubpg8qXJV9IKFic7I9fxFYGbDJTicpcu8ib5GUEuUFwMSfdAYnThsjZ1Q/132, createdBy=1b4f2360060, createdName=爱您一万年, createdTime=Fri May 19 06:07:49 CST 2023, time=2023-05-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1087443, encodeId=ad03108e44387, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016043, encodeId=f50d10160431a, content=偏重的研究方向:肿瘤外科<br>经验分享:10天 under review,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/16aca09327e6e9fe8409019894c494a0.jpg, createdBy=e7772226610, createdName=121148d5m08暂无昵称, createdTime=Thu Sep 09 13:18:28 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544290, encodeId=488d5442903c, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095062, encodeId=3376209506277, content=好中吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3c31972528, createdName=Frontiers主编, createdTime=Thu Oct 20 22:44:01 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087444, encodeId=958d108e44485, content=期刊发送邮件中包括哪几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085116, encodeId=cd051085116d7, content=圣诞节对审稿影响多少,21号投的稿现在没有消息,有没有送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da85597851, createdName=ms8000000068856168, createdTime=Tue Dec 28 15:56:39 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923874, encodeId=d8ad9238e487, content=已under review 5天,还没被拒,说明已送审?<br>应该还不保险,10天左右没被拒,大概是送审了。<br>上一次投稿,4天被拒。期待,不行赶快有结果,好去转投BJS。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Feb 09 11:39:23 CST 2021, time=2021-02-09, status=1, ipAttribution=)]
    2021-12-29 乌云背后的幸福线

    期刊发送邮件中包括哪几个方面的内容?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2155599, encodeId=fd8521555996b, content=记录一下这次不知死活的试探(成功概率P&lt;0.05)<br>under review 16天<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 12:14:46 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2146688, encodeId=4c90214668893, content=投稿命中率:5.0<br>偏重的研究方向:外科<br>经验分享:Under review 17 天,请问多久知道是送审了没有呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu Jul 06 21:45:48 CST 2023, time=2023-07-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2137790, encodeId=f6eb213e79000, content=偏重的研究方向:外科<br>经验分享:期刊收录的都是临床研究,希望中的人多分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KiaoPdfCzZ3xibjx7qwz8Ll35hLHUNHUqFubpg8qXJV9IKFic7I9fxFYGbDJTicpcu8ib5GUEuUFwMSfdAYnThsjZ1Q/132, createdBy=1b4f2360060, createdName=爱您一万年, createdTime=Fri May 19 06:07:49 CST 2023, time=2023-05-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1087443, encodeId=ad03108e44387, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016043, encodeId=f50d10160431a, content=偏重的研究方向:肿瘤外科<br>经验分享:10天 under review,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/16aca09327e6e9fe8409019894c494a0.jpg, createdBy=e7772226610, createdName=121148d5m08暂无昵称, createdTime=Thu Sep 09 13:18:28 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544290, encodeId=488d5442903c, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095062, encodeId=3376209506277, content=好中吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3c31972528, createdName=Frontiers主编, createdTime=Thu Oct 20 22:44:01 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087444, encodeId=958d108e44485, content=期刊发送邮件中包括哪几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085116, encodeId=cd051085116d7, content=圣诞节对审稿影响多少,21号投的稿现在没有消息,有没有送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da85597851, createdName=ms8000000068856168, createdTime=Tue Dec 28 15:56:39 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923874, encodeId=d8ad9238e487, content=已under review 5天,还没被拒,说明已送审?<br>应该还不保险,10天左右没被拒,大概是送审了。<br>上一次投稿,4天被拒。期待,不行赶快有结果,好去转投BJS。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Feb 09 11:39:23 CST 2021, time=2021-02-09, status=1, ipAttribution=)]
    2021-12-28 ms8000000068856168

    圣诞节对审稿影响多少,21号投的稿现在没有消息,有没有送外审

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2155599, encodeId=fd8521555996b, content=记录一下这次不知死活的试探(成功概率P&lt;0.05)<br>under review 16天<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 12:14:46 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2146688, encodeId=4c90214668893, content=投稿命中率:5.0<br>偏重的研究方向:外科<br>经验分享:Under review 17 天,请问多久知道是送审了没有呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Thu Jul 06 21:45:48 CST 2023, time=2023-07-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2137790, encodeId=f6eb213e79000, content=偏重的研究方向:外科<br>经验分享:期刊收录的都是临床研究,希望中的人多分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KiaoPdfCzZ3xibjx7qwz8Ll35hLHUNHUqFubpg8qXJV9IKFic7I9fxFYGbDJTicpcu8ib5GUEuUFwMSfdAYnThsjZ1Q/132, createdBy=1b4f2360060, createdName=爱您一万年, createdTime=Fri May 19 06:07:49 CST 2023, time=2023-05-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1087443, encodeId=ad03108e44387, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016043, encodeId=f50d10160431a, content=偏重的研究方向:肿瘤外科<br>经验分享:10天 under review,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/16aca09327e6e9fe8409019894c494a0.jpg, createdBy=e7772226610, createdName=121148d5m08暂无昵称, createdTime=Thu Sep 09 13:18:28 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544290, encodeId=488d5442903c, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095062, encodeId=3376209506277, content=好中吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3c31972528, createdName=Frontiers主编, createdTime=Thu Oct 20 22:44:01 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087444, encodeId=958d108e44485, content=期刊发送邮件中包括哪几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085116, encodeId=cd051085116d7, content=圣诞节对审稿影响多少,21号投的稿现在没有消息,有没有送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da85597851, createdName=ms8000000068856168, createdTime=Tue Dec 28 15:56:39 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923874, encodeId=d8ad9238e487, content=已under review 5天,还没被拒,说明已送审?<br>应该还不保险,10天左右没被拒,大概是送审了。<br>上一次投稿,4天被拒。期待,不行赶快有结果,好去转投BJS。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Feb 09 11:39:23 CST 2021, time=2021-02-09, status=1, ipAttribution=)]
    2021-02-09 独行er

    已under review 5天,还没被拒,说明已送审?
    应该还不保险,10天左右没被拒,大概是送审了。
    上一次投稿,4天被拒。期待,不行赶快有结果,好去转投BJS。

    9

    展开9条回复
共40条页码: 1/4页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分